The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
- Ann N Y Acad Sci. 1998 Dec 15;861:270-1. doi: 10.1111/j.1749-6632.1998.tb10219.x.
Affiliations
- 1. SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, UK. [email protected]
PMID: 9928285
DOI: 10.1111/j.1749-6632.1998.tb10219.x
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: 5-HT ReceptorResearch Areas: Neurological Disease
-
Research Areas: Neurological Disease